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Summary
LIPUS treatment of the socket of removed first molar tooth from the upper jaws of
retired  breeder  rats  induced  neovascularization  at  the  wound  site.  In  addition,  LIPUS
treatment transiently but significantly increased the baseline blood flow rate  at  feet while
transiently  reducing  the  socket  flow  rate.  In  vivo  preincubation  with  the  EP4  receptor
antagonist  abrogated  the  LIPUS-induced  reduction  in  socket  flow rate,  whereas  the  EP3
antagonist did not. Topical application of PGE2 to the socket also transiently reduced socket
flow rate, whereas topical PGE2 to intact gingival epithelium did not. Moreover, increased
CXCR4-positive tibia bone marrow cells without increased CXCL12 staining suggested the
possibility that PGE2 released from the socket was responsible, at least in part, for the effects
of LIPUS through the circulation directly affecting bone marrow cells. LIPUS exerts humoral
effects on remote tissues through factor(s) released by mechanically stimulated cells in the
healing oral tissues.
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1. Introduction
Low-intensity pulsed ultrasound (LIPUS) has been found to be a potent therapeutic
tool that accelerates many steps of fracture healing  1-3.  These effects are mediated in part
through COX2, as we previously showed in COX2 KO mice, in which the abrogated anabolic
LIPUS effect was restored by injection of EP2 and EP4 agonists  4. These effects have also
been  associated  with  alterations  in  the  expression  of  vascular  endothelial  growth  factor
(VEGF) via a mechanism mediated by prostaglandin E2 (PGE2), accelerating the healing of
fractures in mouse and rat femurs 4;5.
LIPUS was shown to have site specific effects on mechanotransduction of bone cells, in that
the behavior of mandibular osteoblasts differed from the behavior of osteoblasts derived from
long bones and calvaria 6. Mandibular bone remodeling has also shown site specificity, likely
due to different functional demands that reflect occlusion  7.  The effects of LIPUS in oral
environments, in which the immune system remains constitutively active to protect cells from
oral microbiomes, however, have not been well explored. This in vivo study was designed to
determine the responses to LIPUS treatment of tooth sockets following the removal of first
molar teeth and some surrounding tissue from aged female rats. 
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2. Materials and methods
The study protocol was approved by the institutional  Animal  Care Committee of
Kanagawa Dental  University,  Yokosuka,  Japan.  All  procedures involving animals were in
accordance  with  the  guidelines  for  the  Care  and  Use  of  Laboratory  Animals  (ministerial
notification No. 71 by the Minister of Education, Culture, Sports, Science and Technology of
Japan, 2006).
2.1. Reagents
The  EP  antagonists  L-161,982  and  L-798,106  were  purchased  from  Cayman
Chemical  Company  (Ann  Arbor,  MI,  USA).  PGE2 was  from  Wako  Chemical  Company
(Tokyo,  Japan).  Anti-CXCR4 antibody AB2074 was from Abcam PLC (Cambridge,  UK),
anti-CXCL12 antibody was from Affimetrix Inc  (Santa Clara,  CA),  anti-VEGF (147) and
anti-CD34 (C-18) antibodies were from Santa Cruz Biotechnology, Inc. (Dallas, TX, USA).
Alexa Fluor 488 and 546 conjugated to F(ab’)2 secondary antibodies were from Molecular
Probes (Eugene, OR, USA).   
2.2. Removal of rat maxillary first molar teeth
Right  maxillary  first  molars  (M1)  were  removed from 10 female  retired  breeder
Wistar  rats  (Japan  SLC  Inc.,  Hamamatsu,  Japan),  in  2  groups.  Because  the  excessive
cementum apposition on the roots in these aged rats deters extraction, the M1 molars were
removed using a dental air-turbine (Portable Unit-7G; Osada Inc., Japan) and a diamond point
(MaryDia F-010XL; Hinatawada Seimitsu MFG, Co. Ltd.,  Tokyo, Japan. Operations were
performed  under  chloral  hydrate  anesthesia.  Sufficient water  was  provided  to  cool  the
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diamond point and excess water was vacuumed. 
2.3. LIPUS treatment
The  custom-built  sonic-accelerated  fracture-healing  system  for  animals  (Teijin
Limited, Japan) included transducers 13-mm in diameter, providing US at a frequency of 1.5
MHz and a repetition frequency of 1 kHz, with pulse burst width of 200 μs and intensity of 30
mW/cm2. Starting the day after M1 removal, the rats were anesthetized daily with isoflurane
and a LIPUS probe was attached to the smooth shaven cheek of each rat using high viscosity
gel, with clay used to direct the probe toward the socket. The rats were placed onto a warm
plate set at 37 ºC, and the M1 sockets of five rats were exposed to LIPUS for 20 min every 24
hours. Five control rats received mock treatment. 
2.4. Blood flow measurements
Blood flow on days 3, 7, 11 and 14 after surgery was measured before and after
LIPUS or mock treatment. A TBF-LN1 laser Doppler flowmeter (Unique Medical Co., Ltd.,
Tokyo, Japan) with a 2.0 mm probe was placed at the surfaces of the M1 socket, the center of
the tail and the dorsum of the foot.  Some rats were injected 20 min before LIPUS treatment
with a sufficient amount of the EP 4 receptor antagonist L-161,982 or the EP3 antagonist, L-
798,106 to yield a concentration of 1 μM, assuming a blood volume of 15 mL through the tail
vein. As a negative control, 100 L 1.0 % DMSO was injected. 
2.5. Immunohistochemical analysis
After LIPUS treatment for 2-weeks, isolated tissue pieces were trimmed and fixed
with 4% PFA for two days, placed in 10 % sucrose and 20 % sucrose for more than 2 days
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each and into Super Cryo Embedding Medium (SCEM; Leica Microsystems Japan; Tokyo,
Japan), and frozen at -103 ºC in a UT-2000F cooling unit (Tokyo Rikakikai, Co., Ltd; Tokyo,
Japan), which uses as coolant a solution of equal volumes of hexane and isopentane. In a
cryomicrotome (CM3050S, Leica Microsystems GmbH, Wetzlar, Germany), the sample block
surface was covered with an adhesive thin plastic Cryofilm II(9) (Leica Microsystems) and
serial 3-μm thick frozen undecalcified sections were cut and placed on the films. The sections
on the films were fixed and stored in 70% ethanol at  -20 ºC. Except for VEGF staining,
samples were decalcified with 10% formic acid for 10 min prior to  immunostaining.  The
sections were washed three times with phosphate-buffered saline (PBS), treated with 0.1%
Triton X-100/PBS for 10 min, washed another 3 times with PBS, and incubated for 2 h at
room temperature  with  primary  antibodies  against  VEGF  (1:50),  CD34  (1:50),  CXCL12
(1:100) and CXCR4 (1:1,000), all diluted in blocking PBS solution containing 1.5% normal
goat serum and 0.05% Triton X-100. The sections were washed with PBS and subsequently
incubated  for  1  h  with  fluorochrome-conjugates  (Alexa  488  and  546)  of  the  respective
secondary antibodies, diluted 1:1,000 in blocking PBS solution. The samples were viewed
using  an  AxioImager  Z1  microscope  (Carl  Zeiss  AG,  Oberkochen,  Germany)  at  the
appropriate  excitation  wavelength  depending  on  the  fluorochrome.  As  negative  controls,
sections were prepared without primary antibodies.
2.6. Statistical analysis
Baseline characteristics were compared using the Holm-Sidak test and changes over time 
after LIPUS exposure using paired t-tests, All statistical analyses were performed using 
GraphPad Prism 6 (GraphPad Software, San Diego, CA), with p values < 0.05 defined as 
statistically significant. Data are presented as the mean ± SD.
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3. Results
3.1. Histological evaluation of LIPUS effect on peripheral blood vessel formation. 
Hematoxylin  and eosin  stained sections  of  M1 tooth  sockets  showed granulation
tissue after exposure to LIPUS for 2-weeks (Fig. 1). Areas particularly rich in blood vessels
were observed between the granulation tissue and alveolar bone, areas in the healing socket
can be reached by LIPUS pulses of 30 mW/cm1.  LIPUS increased the density of vessels
possibly  the  width  as  well  (Fig.  1(B)).  LIPUS-associated  neovascularization  was  also
observed by fluorescence with anti-CD34 antibody (Fig. 2A). A similar area, as well as the
granulation tissue adjoining the area of CD34 positivity, was highly stained by anti-VEGF
antibody  (Fig.  2B).  Little  staining  was  observed  when  primary  antibodies  were  omitted,
followed by staining with Alexa488 and 546 conjugated secondary antibodies against goat or
rabbit IgG (data not shown).
3.2. LIPUS exposure increased blood flow rate at the wound site
Baseline  flow  rates  were  measured  at  three  anatomic  sites  prior  to  the  daily
LIPUS/mock treatment (Fig. 3). Baseline flow rates in M1 sockets were significantly higher
on days 7 and 14 in LIPUS-exposed than in control rats. A similar trend was seen on day 11,
but not on day 3. Baseline flow rates in the intact gingiva before tooth removal (day 0) near
the M1 tooth were significantly higher than after tooth removal on days 3, 7, 11 and 14. 
3.3. Transient effect of LIPUS exposure on blood flow rates
Flow rates over time in the M1 socket immediately after LIPUS treatment for 20 min
on days 7, 11 and 14 are shown in Fig. 4A. Five min after the end of LIPUS treatment, flow
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rates were slightly lower than at baseline. The flow rate further declined until 15 to 20 min
after treatment, returning to near-basal levels after about 1 h. Mean actual flow rates 20 min
after treatment are shown in Fig. 4B. Starting on day 7, but not on day 3, blood flow rate was
significantly lower in the socket but was higher in the foot after than before treatment. Similar
results were seen on days 11 and 14. The blood flow rate in the tail, which is also remote from
the  wound/LIPUS  exposure  site,  tended  to  be  elevated.  Injection  of  the  EP4  receptor
antagonist L-161,982 prior to LIPUS treatment completely abrogated the effects of LIPUS
treatment, whereas the EP3 receptor antagonist L-798,106 had no effect, suggesting that the
effects of LIPUS are dependent on PGE2 (Fig. 4C). In contrast, topical application of PGE2 to
socket epithelium mimicked the effects of LIPUS by reducing the blood flow rate  in the
socket. 
3.4.  Effect  of  LIPUS on  the  CXCL12-CXCR4 axis  of  cell  recruitment  from tibial  bone
marrow
Levels of CXCR4 and CXCL12 proteins were assessed immunochemically in bone
marrow cells of the sagittal sections of tibias derived from a LIPUS-treated and a control rat
in Fig. 5. In Fig. 5(A), the area depicted in Fig. 5(B) and (C) was framed in a film section of
proximal half of the whole tibia. With CXCR4 antibody, more intense staining was detected in
LIPUS-treated rat bone marrow. No difference was seen with CXCL12 antibody.
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3. Discussion
Results show that LIPUS induced neovascularization and increased the density and 
possibly the width of peripheral blood vessels in the wound site of sockets from which teeth 
had been removed. Immunohistochemical analysis showed increased CD34 and VEGF 
staining, indicating that LIPUS had angiogenic effects in the socket. LIPUS exposur increased
the baseline blood flow rate in the socket, suggesting that LIPUS increased the width of 
peripheral blood vessels in the socket. Elevated blood flow was not observed in the tail or the 
foot, indicating that the effects of socket LIPUS exposure did not alter the blood vessels at 
distant sites. LIPUS exposure also transiently reduced blood flow rate in the socket, beginning
after 7 days of LIPUS exposure, accompanied by increased blood flow rates at remote sites 
such as the feet. Pretreatment with EP receptor antagonists indicated that LIPUS promoted the
angiogenesis through PGE2, which has been found to elevate blood flow rates 8. Endothelial 
cells derived from circulating cells may be a subset of cells mobilized from bone marrow, 
which circulate in peripheral blood and participate in neovascularization at remote sites 9;10.
During angiogenesis, PGE2 binds to specific receptors on bone marrow-derived cells 
(BMCs), stimulating these cells and significantly increasing their differentiation and 
migration, as well as significantly upregulating CD31 (34) and von Willebrand factor, both 
markers of differentiation to endothelial cells 11. We have reported that COX2 plays an 
essential role in the effects of LIPUS, by upregulating VEGF during fracture healing, 
inasmuch as EP2 and EP4 agonists liberated the effects of LIPUS, which was eliminated in 
COX2 KO mice 4. PGE2 involvement in the effects of LIPUS were also shown by the ability 
of LIPUS to restore delayed union of fractures in aged wild type mice 4, in good agreement 
with findings showing that PGE2 treatment induced the proliferation of massive progenitor 
cells in aged skeletons 12. Mechanisms responsible for age-associated impairments in 
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angiogenesis are thought to include age-related endothelial dysfunction and reduced VEGF 
expression. Advanced age, however, does not preclude augmentation of collateral vessel 
development in response to exogenous angiogenic cytokines 13.
While mechanical stimulation of cells at the wound site may also induce other as-yet-
undetermined molecules which propagate effects to tissues remote from the healing oral 
tissues, PGE2 has long been reported to stimulate the proliferation of hematopoietic stem cells
and progenitor cells 14;15. Animal and human cells exposed in vitro and ex vivo to 16-16 
dimethyl PGE2 (dmPGE2), a long-acting analog of PGE2 showed enhanced hematopoietic 
colony formation and/or engraftment 16-18. Moreover, dmPGE2 treatment of hematopoietic 
stem and progenitor cells has been found to stabilize the transcription factor HIF1α which, in 
turn, increases the expression of CXCR4, a key enhancer of stem and progenitor cell homing 
and engraftment in the CXCL12 (SDF-1)-CXCR4 axis 19. Moreover, HIF1α is one of the 
mediators induced by LIPUS 20. Speth et al. showed that PGE2 enhances hematopoietic stem 
and progenitor cell homing primarily by increasing CXCR4 expression through the specific 
hypoxia response element, HRE, which is required for CXCR4 upregulation 19. In our result 
of increased CXCR4-positive cells we observed in the remote tibial bone marrow of LIPUS 
treated rats in Fig. 5, circulating PGE2, which can increase baseline blood flow in foot, may 
also have induced CXCR4 expression resulting in CXCR4-positive hematopoietic stem and 
progenitor cells in tibia bone marrow. In fact, PGE2 concentrations in plasma drawn from rat 
tails 20 min after LIPUS treatment were 3 to 4 times higher than the values before tooth 
removal and those of mock-treated rats (data not shown). Moreover, the LIPUS effect on 
fracture healing in CXCL12 (SDF-1)-CXCR4 axis was conceived by Kumagai et al., as 
transport of osteogenic progenitor cells (CXCR4-positive) to the fracture site (CXCL12-
positive) by systemic circulation 21. In parabiotic green fluorescent protein (GFP) mouse with 
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wild type mouse, whose femur was fractured, compared to the vehicle-treated wild type 
mouse, LIPUS-treated wild type mouse showed significantly more GFP cells, apparently 
recruited from the adjacent GFP animal. At 2 weeks post-operation, the LIPUS treated 
fracture site was populated with CXCR4-positive GFP cells, which were virtually absent in 
control fractures. CXCR4 is expressed on the surface of recruited cells and is the receptor for 
chemokine CXCL12 (SDF-1), which is significantly increased in the LIPUS treated fracture 
site 21. A key role of CXCL12 (SDF-1) in the homing of CXCR4-positive circulating cells to 
sites of tissue repair was reported 22-24, but in the present study we did not detect increased 
CXCL12 in the bone marrow of foot.
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Figure legends
Fig. 1   
Histologic morphology of healing sockets with regenerated gingival epithelium after LIPUS
treatment  for  2  weeks  (hematoxylin  and  eosin  staining  of  3-m  thick  sections  after
decalcification with 10% formic acid; original magnification x4 for (A) and (C) and x10 for
(B) and (D)). (A) and (B) from a LIPUS treated rat; (C) and (D) from a control rat. Squared
areas in (A) and (C) were magnified in (B) and (D). Scale bars = 300 m.
Fig. 2   
Profiles of CD34 and VEGF immunohistochemical staining of healing sockets after LIPUS
treatment for two weeks. Socket tissue sections from a LIPUS-treated rat in (A) and (C), and
from a control rat in (B) and (D) were incubated with anti-CD34 primary antibody and Alexa
488 conjugated secondary antibody in (A) and (B) or anti-VEGF primary antibody and Alexa
546 conjugated secondary antibody in (C, D). Intensity was greater in sections from LIPUS
treated than control rats. Arrowheads indicate the areas of intense staining. Scale bars = 300
m.
Fig. 3   
Effect  of daily LIPUS treatment  for  two weeks on baseline blood flow rates.  (A) Socket
baseline flow rates in the LIPUS (open squares) and mock treated (filled squares) groups. A
half-filled square represents the blood flow rate at the epithelium near the first molar gingiva
prior to removal of the tooth. Blood flow rates were significantly higher in the LIPUS group
rats after 7 but not 3 days. Data are presented as the mean ± SD. Single asterisks represent p
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<0.05. (B and C) Blood flow rates in rat tails (B) and feet (C). 
Fig. 4   
Transient effect of LIPUS on blood flow rates after LIPUS treatment for 20 min. (A) Typical
time course profiles of LIPUS treated rats on days 7 (filled squares, #1 rat), 11 (lined squares,
#2  rat)  and  14  (open  squares,  #6  rat).  Baseline  values  measured  20  min  before  LIPUS
treatment. (B) Effect of LIPUS treatment on blood flow rates 20 min after LIPUS exposure
for 20 min on post-operational days 3, 7, 11 and 14. Flow rates in the socket, tail, and foot 20
min after treatment (lined squares) were compared with baseline rates just prior to treatment
(open squares). Flow rates in the socket after LIPUS treatment were significantly lower after
day 7 but not on day 3. In contrast, flow rates in the feet and tails on days 11 and 14 were
higher 20 min after LIPUS than at baseline. Data are presented as the mean ± SD. Asterisks
represent * p < 0.05, ** p < 0.005 and **** p < 0.0001 by paired t-test.
 (C) Effects of LIPUS on socket blood flow rate on day 14 in rats administered the EP3
antagonist  L-798,106  (dotted  squares  with  dotted  line)  or  the  EP4  antagonist  L-161,982
(meshed squares with dashed line) 20 min before LIPUS treatment relative to untreated rats
(open squares and dashed dotted line), and effect of topically application of 2 L 1 mM PGE2
on socket epithelium of a LIPUS-treated rat on day 14 (filled squares, solid lines).
Fig. 5   
Profiles  of  CXCR4  immunohistochemical  staining  of  tibial  bone  marrow  after  LIPUS
treatment for two weeks. (A) sagittal section of the proximal end of tibia prepared on a film;
equivalent areas to that in the box were observed in the figures (B) for the LIPUS-treated rat
and (C) for the control rat. Tissue sections were stained with anti-CXCR4 primary antibody
17
and Alexa 546 conjugated secondary antibody. Scale bar = 1 mm in (A) and 100 m in (B)
and (C). Note that more cells with intense staining were seen in (B) than in (C).
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